Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP6V0A2 | CTRPv2 | pan-cancer | AAC | 0.48 | 7e-05 |
mRNA | KDELR3 | CTRPv2 | pan-cancer | AAC | -0.55 | 8e-05 |
mRNA | SUMF1 | CTRPv2 | pan-cancer | AAC | -0.42 | 8e-05 |
mRNA | MND1 | CTRPv2 | pan-cancer | AAC | 0.55 | 8e-05 |
mRNA | NIPAL3 | CTRPv2 | pan-cancer | AAC | -0.41 | 9e-05 |
mRNA | VBP1 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0001 |
mRNA | PDCD2 | CTRPv2 | pan-cancer | AAC | 0.48 | 0.0001 |
mRNA | EMP1 | CTRPv2 | pan-cancer | AAC | -0.51 | 0.0001 |
mRNA | TK2 | CTRPv2 | pan-cancer | AAC | -0.49 | 0.0001 |
mRNA | INTS7 | CTRPv2 | pan-cancer | AAC | 0.45 | 0.0001 |